文献速递痛风与晶体性关节病

痛风患者尿液与血清代谢组学特征识别

Identification of the urine and serum metabolomics signature of gout.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究通过UPLC-MS分析30例痛风患者与30例年龄匹配健康对照的血清和尿液,筛选差异代谢物并构建诊断模型,在100例验证队列中验证优化;最终由焦谷氨酸、2-甲基丁酰肉碱和Phe-Phe三种血清代谢物组成的模型曲线下面积为0.956(95%CI 0.911, 1.000)。

要点

  • 血清代谢组学区分痛风与健康对照优于尿液代谢组学。
  • 三种血清代谢物组成的诊断模型曲线下面积为0.956(95%CI 0.911, 1.000)。
  • 相关代谢通路涉及嘌呤代谢、支链氨基酸代谢、三羧酸循环等。

核心结论

  • 代谢组学特征可作为痛风早期诊断的有效工具,并为痛风发病机制提供新见解。

研究设计与样本

  • 发现队列纳入痛风患者30例和年龄匹配健康对照30例,采用UPLC-MS分析血清和尿液筛选差异代谢物并构建诊断模型。
  • 验证队列纳入100例,对模型进行验证和优化,并阐释相关代谢通路。

主要发现

  • 血清代谢组学比尿液代谢组学表现出更清晰的区分度。
  • 发现队列中鉴定出40种可区分痛风患者与健康对照的差异血清代谢物。
  • 验证队列中验证了8种血清代谢物。
  • 通过回归分析,最终模型由焦谷氨酸、2-甲基丁酰肉碱和Phe-Phe三种血清代谢物组成,具有最佳诊断效能。
  • 三种代谢物模型的曲线下面积为0.956(95%CI 0.911, 1.000)。

关键数值与推荐

  • 诊断模型曲线下面积为0.956(95%CI 0.911, 1.000)。
  • 提出的代谢通路主要涉及嘌呤代谢、支链氨基酸(BCAAs)代谢、三羧酸循环、酮体合成与降解、胆汁分泌和花生四烯酸代谢。

临床怎么用

  • 血清代谢组学特征(焦谷氨酸、2-甲基丁酰肉碱和Phe-Phe)可作为痛风早期诊断的候选工具。
  • 相关代谢通路为理解痛风发病机制提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gout is the most common inflammatory arthritis and the worldwide incidence is increasing. By revealing the metabolic alterations in serum and urine of gout patients, the first aim of our study was to discover novel molecular biomarkers allowing for early diagnosis. We also aimed to investigate the underlying pathogenic pathways. METHODS: Serum and urine samples from gout patients (n = 30) and age-matched healthy controls (n = 30) were analysed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) to screen the differential metabolites and construct a diagnostic model. Next, the model was verified and optimized in the second validation cohort (n = 100). The pathways were illustrated to understand the underlying pathogenesis of gout. RESULTS: In general, serum metabolomics demonstrated a clearer distinction than urine metabolomics. In the discovery cohort, 40 differential serum metabolites were identified that could distinguish gout patients from healthy controls. Among them, eight serum metabolites were verified in the validation cohort. Through regression analysis, the final model consisted of three serum metabolites-pyroglutamic acid, 2-methylbutyryl carnitine and Phe-Phe-that presented optimal diagnostic power. The three proposed metabolites produced an area under the curve of 0.956 (95% CI 0.911, 1.000). Additionally, the proposed metabolic pathways were primarily involved in purine metabolism, branched-chain amino acids (BCAAs) metabolism, the tricarboxylic acid cycle, synthesis and degradation of ketone bodies, bile secretion and arachidonic acid metabolism. CONCLUSION: The metabolomics signatures could serve as an efficient tool for early diagnosis and provide novel insights into the pathogenesis of gout.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Huang Y, Xiao M, Ou J, et al. Identification of the urine and serum metabolomics signature of gout. Rheumatology (Oxford). 2020. PMID: 32134107. doi:10.1093/rheumatology/keaa018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。